NYSE:CLB Core Laboratories (CLB) Stock Price, News & Analysis $7.92 -0.48 (-5.71%) As of 12:03 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Core Laboratories Stock (NYSE:CLB) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Core Laboratories alerts:Sign Up Key Stats Today's Range$7.85▼$8.3750-Day Range$8.37▼$12.5052-Week Range$7.85▼$20.36Volume247,517 shsAverage Volume595,678 shsMarket Capitalization$362.89 millionP/E Ratio20.83Dividend Yield0.51%Price Target$21.00Consensus RatingHold Company Overview Core Laboratories Inc. provides specialized services and products to the oil and natural gas industry. Its work helps customers evaluate reservoirs and improve the performance of producing wells. The company’s Reservoir Description business analyzes rock and fluid samples and provides laboratory testing, data, and reservoir studies. These services help energy companies assess subsurface properties and make decisions about exploration and field development. Through its Production Enhancement business, Core Laboratories offers well diagnostics, completion-related services, and technologies designed to support production and improve recovery. The company serves energy customers internationally, with operations across major oil and gas regions.AI Generated. May Contain Errors. Read More Core Laboratories Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks64th Percentile Overall ScoreCLB MarketRank™: 3.21330401319 of 5 starsCore Laboratories scored higher than 64% of companies evaluated by MarketBeat, and ranked 157th out of 239 stocks in the energy sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.2 / 5Analyst RatingHold Consensus RatingCore Laboratories has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 1 buy rating, no hold ratings, and 1 sell rating.Upside PotentialCore Laboratories has a consensus price target of $21.00, representing about 155.6% upside from its current price of $8.22.Amount of Analyst CoverageCore Laboratories has only been the subject of 1 research reports in the past 90 days.Read more about Core Laboratories' stock forecast and price target. Earnings and Valuation3.1 / 5Proj. Earnings Growth41.07% Earnings GrowthEarnings for Core Laboratories are expected to grow by 41.07% in the coming year, from $0.56 to $0.79 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Core Laboratories is 21.89, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 25.09.Price to Earnings Ratio vs. SectorThe P/E ratio of Core Laboratories is 21.89, which means that it is trading at a less expensive P/E ratio than the Energy sector average P/E ratio of about 21.95.Price to Earnings Growth RatioCore Laboratories has a PEG Ratio of 1.70. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioCore Laboratories has a P/B Ratio of 1.33. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Core Laboratories' valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted10.95% of the float of Core Laboratories has been sold short.Short Interest Ratio / Days to CoverCore Laboratories has a short interest ratio ("days to cover") of 6.76.Change versus previous monthShort interest in Core Laboratories has recently increased by 0.76%, indicating that investor sentiment is decreasing. Dividend1.7 / 5Dividend StrengthWeak Dividend YieldCore Laboratories has a dividend yield of 0.47%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthCore Laboratories does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Core Laboratories is 10.53%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Core Laboratories will have a dividend payout ratio of 5.06% next year. This indicates that Core Laboratories will be able to sustain or increase its dividend.Read more about Core Laboratories' dividend. News and Social Media1.2 / 5News Sentiment-0.15 News SentimentCore Laboratories has a news sentiment score of -0.15. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.58 average news sentiment score of Energy companies.News Coverage This WeekMarketBeat has tracked 7 news articles for Core Laboratories this week, compared to 2 articles on an average week. Company Ownership0.8 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Core Laboratories insiders have not sold or bought any company stock.Percentage Held by Insiders1.26% of the stock of Core Laboratories is held by insiders.Percentage Held by Institutions97.81% of the stock of Core Laboratories is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Core Laboratories' insider trading history. Receive CLB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Core Laboratories and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CLB Stock News HeadlinesCLB Q3 Earnings Miss Estimates on Higher Costs and DisruptionsNovember 3, 2026 | finance.yahoo.comCore Laboratories (CLB) Q3 2026 Earnings Call TranscriptOctober 31, 2026 | finance.yahoo.comYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.November 20 at 1:00 AM | Profits Run (Ad)CLB Q3 deep dive: Geopolitical disruptions weigh on operations, management expects global CapEx recoveryOctober 31, 2026 | finance.yahoo.comThe most interesting analyst questions from Core Laboratories’s Q3 earnings callOctober 30, 2026 | msn.comCore Laboratories (CLB) Stock Price Shrugs At Q3 Results As Margins TightenOctober 30, 2026 | finance.yahoo.comTranscript : Core Laboratories Inc., Q3 2026 Earnings Call, Oct 29, 2026October 29, 2026 | marketscreener.comMCore Laboratories Inc. Approves Cash Dividend, Payable on November 30, 2026October 29, 2026 | marketscreener.comMSee More Headlines CLB Stock Analysis - Frequently Asked Questions How have CLB shares performed this year? Core Laboratories' stock was trading at $16.02 at the start of the year. Since then, CLB stock has decreased by 48.7% and is now trading at $8.2160. How were Core Laboratories' earnings last quarter? Core Laboratories Inc. (NYSE:CLB) announced its quarterly earnings data on Wednesday, October, 28th. The oil and gas company reported $0.16 EPS for the quarter, beating analysts' consensus estimates of $0.16 by $0.00. Core Laboratories's quarterly revenue was down 1.8% on a year-over-year basis. Read the conference call transcript. Who are Core Laboratories' major shareholders? Core Laboratories' top institutional shareholders include State Street Corp (3.40%), Heartland Advisors Inc. (2.44%), Goldman Sachs Group Inc. (1.63%) and Archon Capital Management LLC (0.98%). View institutional ownership trends. How do I buy shares of Core Laboratories? Shares of CLB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Core Laboratories own? Based on aggregate information from My MarketBeat watchlists, some other companies that Core Laboratories investors own include Netflix (NFLX), Boeing (BA), Gilead Sciences (GILD), Micron Technology (MU), Starbucks (SBUX), Mastercard (MA) and Intel (INTC). Company Calendar Record date for 8/31 Dividend8/10/2026Ex-Dividend for 8/31 Dividend8/10/2026Dividend Payable8/31/2026Last Earnings10/28/2026Record date for 11/30 Dividend11/09/2026Ex-Dividend for 11/30 Dividend11/09/2026Today11/20/2026Dividend Payable11/30/2026Fiscal Year End12/31/2026Next Earnings (Estimated)2/03/2027Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (5m+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 CLB's financial health is in the Red zone, according to TradeSmith. CLB has been in this zone for over 5 months. Industry, Sector and Symbol Stock ExchangeNYSE SectorEnergy Industry Energy Equipment & Services Sub-IndustryOil & Gas Equipment & Services Current SymbolNYSE:CLB CIK1958086 Webwww.corelab.com Phone(713) 328-2673FaxN/AEmployees3,300Year Founded1936Price Target and Rating Average Price Target for Core Laboratories$21.00 High Price Target$21.00 Low Price Target$21.00 Potential Upside/Downside+165.2%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage2 Analysts Profitability EPS (Trailing Twelve Months)$0.38 Trailing P/E Ratio20.83 Forward P/E Ratio10.03 P/E Growth1.7Net Income$29.67 million Net Margins3.42% Pretax Margin5.38% Return on Equity8.94% Return on Assets4.22% Debt Debt-to-Equity Ratio0.40 Current Ratio2.19 Quick Ratio1.60 Sales & Book Value Annual Sales$526.52 million Price / Sales0.69 Cash Flow$1.00 per share Price / Cash Flow7.91 Book Value$6.20 per share Price / Book1.28Miscellaneous Outstanding Shares45,820,000Free Float45,246,000Market Cap$362.89 million OptionableOptionable Beta1.18 Social Links 7 Stocks to Buy Before the Robotics RevolutionRobotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.Get This Free Report This page (NYSE:CLB) was last updated on 11/20/2026 by MarketBeat.com Staff. From Our PartnersYour $7 scanner is waitingThe Instant Scanner is $7 in Bill Poulos's Black Friday sale. Every night it delivers a list showing which sto...Profits Run | SponsoredWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredYour Social Security check is scheduled for a 22% cutThe U.S. now borrows money just to pay interest on money it already borrowed, a pattern economists call a debt...American Alternative | SponsoredI'm handing you this one freeDylan has tracked down the company behind what he calls the StarChip. It's already inside more than 10,000 Sta...Behind the Markets | SponsoredYour father's savings lost half their value after 1971.On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredELON + YOU + DECEMBER 8THElon Musk's next big project may be the most ambitious move of his career, and all signs point to December 8th...Paradigm Press | SponsoredA Bill Would Reprice America's Gold at Market ValueThe US government still values its gold at $42 an ounce, a price Congress set in 1973. Gold trades above $4,00...Concord Gold Capital | SponsoredDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratin...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Core Laboratories Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Core Laboratories With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.